Literature DB >> 23760705

How to approach hypercalcaemia.

Rachel Crowley1, Neil Gittoes.   

Abstract

The management of patients with hypercalcaemia should be informed by the patient's symptoms and signs, by the degree of elevation of calcium, by the underlying mechanism by which calcium has been elevated and by the disease process underlying the presentation. Regardless of diagnosis, all significantly hypercalcaemic patients should be rendered euvolaemic before any further and more specific treatment is considered. Highly symptomatic patients and those with a calcium level of > 3.5 mmol represent a medical emergency that requires inpatient treatment.

Entities:  

Keywords:  Hypercalcaemia; bisphosphonates; hyperparathyroidism; malignancy; vitamin D

Mesh:

Substances:

Year:  2013        PMID: 23760705      PMCID: PMC5922675          DOI: 10.7861/clinmedicine.13-3-287

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  3 in total

1.  Unexpected hypercalcemia in a diabetic patient with kidney disease.

Authors:  Rosaria Lupica; Michele Buemi; Alfredo Campennì; Domenico Trimboli; Valeria Canale; Valeria Cernaro; Domenico Santoro
Journal:  World J Nephrol       Date:  2015-07-06

Review 2.  Endocrine check-up in adolescents and indications for referral: A guide for health care providers.

Authors:  Vincenzo De Sanctis; Ashraf T Soliman; Bernadette Fiscina; Heba Elsedfy; Rania Elalaily; Mohamed Yassin; Nicos Skordis; Salvatore Di Maio; Giorgio Piacentini; Mohamed El Kholy
Journal:  Indian J Endocrinol Metab       Date:  2014-11

3.  Macrophage depletion by free bisphosphonates and zoledronate-loaded red blood cells.

Authors:  Raffaella Sabatino; Antonella Antonelli; Serafina Battistelli; Reto Schwendener; Mauro Magnani; Luigia Rossi
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.